As we noted here, Abbott Labs is splitting in two. The board formally approved it and set a December 12 record date for a January 1 dividend date. Meanwhile, the stock price has not recovered from the body blow delivered by the failure of its kidney/diabetes drug test. Potentially Opps Tracker candidate? We’ll take a look.
Abbott Labs Form 8-K